EpiVario Inc. is pioneering epigenetic therapeutics for modern-day treatments of neuropsychiatric disorders. Spun out of the Epigenetics Institute of the University of Pennsylvania, the company develops pharmacotherapeutics that target a newly discovered epigenetic process in long-term memory. By targeting this activity to modulate stress- and drug-related memories, Epivario is creating a novel, highly effective approach to treating PTSD and substance use disorders.

Contact

Website: https://www.epivario.com/
LinkedIn: https://www.linkedin.com/company/epivario/